4 Just-Revealed Facts as the New COVID-19 Vaccines Are Released

Federal health officials suggest the new COVID shots, which are not boosters, could be available as soon as this week. Here's what's known about who will be eligible first.

The new COVID-19 vaccine is expected to be available in the next few days, possibly as soon as September 13, and is expected to help protect against severe disease and death from the XBB.1.5, the Omicron subvariant.

This week the US Food and Drug Administration has (FDA) authorized updated COVID vaccines made by Pfizer, BioNTech and Moderna for use in adults and children ages six months and up. (Vaccine maker Novavax said the FDA was still reviewing its shot.)

Now it’s up to the Centers for Disease Control and Prevention’s (CDC) independent panel of advisors to provide a recommendation on who will be eligible to receive this phase of the shots. After this decision, millions of doses will be shipped to pharmacies, clinics, and health systems nationwide.

“The public can be assured that these updated vaccines have met the agency’s rigorous scientific standards for safety, effectiveness, and manufacturing quality. We very much encourage those who are eligible to consider getting vaccinated,” says Dr. Peter Marks, director of FDA’s Center for Biologics Evaluation and Research, in a news release.

Get The Healthy @Reader’s Digest newsletter for the latest in health and wellness

1. The new COVID vaccines are not boosters

The new COVID vaccine is not a booster. It is an updated vaccine that targets one new strain, similar to the yearly flu shot.

The original vaccines targeted both BA.4/5 and the wild-type strain, but the 2023 COVID vaccine is aimed at XBB.1.5. Media reports suggest that these vaccines should also protect against newer COVID-19 variants like BA.2.86.

Here’s the Arm You Should Get Your COVID Shot In, New Study Finds

2. Secure your appointment as soon as you are eligible

It’s probably been a while since you had a COVID-19 shot, so it’s likely time to roll up your sleeves again, says Marcus Plescia,  MD, MPH, the chief medical officer for the Association of State and Territorial Health Officials. “This vaccine is really important, particularly for people at high risk for severe COVID-19, such as older people and those who have underlying medical problems.”

Jay W. Lee, MD, MPH, agrees. Dr. Lee is a member of the board of directors of the American Academy of Family Physicians and the Chief Medical Officer at Share Our Selves, a federally qualified health center in Orange County, CA. “Ample data from previous iterations of the vaccine show that it is safe,” he says. “Getting the vaccine is among the most effective ways to prevent serious illness now that people aren’t routinely wearing masks or avoiding large crowds. We know that people who have been vaccinated or have had COVID-19  in the past do better and are less likely to become seriously ill or die.”

Here’s How Long the COVID-19 Vaccine Really Works, Says New Study

3. The new COVID-19 vaccine is available at no cost to most individuals

The original COVID-19 vaccines and boosters were free due to the Public Health Emergency (PHE). Good news, though, according to a spokesperson for the COVID-19 Education and Equity Project who contacted our editors on September 14, 2023: “[…V]accines will actually still be available and free of costs to virtually everyone regardless of insurance type or status. In fact, access to vaccines has never been better,” she says.

This Smart COVID Test Should Be on Your Radar

4. The COVID-19 vaccine one of several vaccines to consider this cold and flu season

Other vaccines include the new flu shot and newly authorized respiratory syncytial virus (RSV) shots for folks aged 60 and older, including Pfizer’s ABRYSVO and GSK’s AREXVY.

Make a plan with your doctor, advised Patricia M. D’Antonio, Vice President of Policy and Professional Affairs for the Gerontological Society of America (GSA) and a geriatric pharmacist, during a September 12 press conference hosted by the National Press Foundation. “You can have the vaccines administered at the same time.”

Denise Mann, MS
Denise Mann is a freelance health writer whose articles regularly appear in WebMD, HealthDay, and other consumer health portals. She has received numerous awards, including the Arthritis Foundation's Northeast Region Prize for Online Journalism; the Excellence in Women's Health Research Journalism Award; the Journalistic Achievement Award from the American Society for Aesthetic Plastic Surgery; National Newsmaker of the Year by the Community Anti-Drug Coalitions of America; the Gold Award for Best Service Journalism from the Magazine Association of the Southeast; a Bronze Award from The American Society of Healthcare Publication Editors (for a cover story she wrote in Plastic Surgery Practice magazine); and an honorable mention in the International Osteoporosis Foundation Journalism Awards. She was part of the writing team awarded a 2008 Sigma Delta Chi award for her part in a WebMD series on autism. Her first foray into health reporting was with the Medical Tribune News Service, where her articles appeared regularly in such newspapers as the Detroit Free Press, Chicago Sun-Times, Dallas Morning News, and Los Angeles Daily News. Mann received a graduate degree from the Medill School of Journalism at Northwestern University in Evanston, Ill., and her undergraduate degree from Lehigh University in Bethlehem, Pa. She lives in New York with her husband David; sons Teddy and Evan; and their miniature schnauzer, Perri Winkle Blu.